Pharmaceuticals, Biotechnology and Life Sciences
– SER-301 is designed to target the physiological triggers of inflammation believed to be central to the underlying pathology of…
Interim data suggest clinically meaningful impact on patient recovery from COVID-19 with an estimated 37 percent more recoveries observed in…
Interim data suggest clinically meaningful impact on patient recovery from COVID-19 with an estimated 37 percent more recoveries observed in…
Approval based on Phase 3 CheckMate -9LA trial results showing superior overall survival in patients with metastatic non-small cell lung…
Approval based on Phase 3 CheckMate -9LA trial results showing superior overall survival in patients with metastatic non-small cell lung…
Late-breaking data to be presented at ACR Convergence: the American College of Rheumatology/Association of Rheumatology Professionals’ Virtual Meeting NEW YORK–(BUSINESS…
Late-breaking data to be presented at ACR Convergence: the American College of Rheumatology/Association of Rheumatology Professionals’ Virtual Meeting NEW YORK–(BUSINESS…
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Anti-Viral Therapies Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Type, Mechanism of…
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Anti-Viral Therapies Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Type, Mechanism of…
Partnership with Huadong Medicine Accelerates Development and Commercialization of Mirvetuximab Soravtansine in Greater China Encouraging Anti-Tumor Activity and Tolerability Data…